Biocytogen Pharmaceuticals (Beijing). (2315.HK) Q1 2024 Earnings

27MarConfirmed
Q2 2022
Q4 2022
Q2 2023
Q1 2024
-0.53
-0.51
-0.5
-0.48

Details

Expected EPS
-0.4848597864
Actual EPS
-0.5289379488
Surprise EPS
-0.04
Surprise Percent
+9.09%

Description

Biocytogen Pharmaceuticals (Beijing). (2315.HK) has reported earnings of -0.5289379488 per share for Q1 2024.

0 Comments

Share your thoughts